| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Dong,Jun-Ren | Chairman | 13.08% | NENG LV INTERNATIONAL CO., LTD. |
| Dong,Jun-Yi | Vice Chairman | 13.08% | NENG LV INTERNATIONAL CO., LTD. |
| Huang,Li-An | Director | 13.08% | NENG LV INTERNATIONAL CO., LTD. |
| Hu,Xiang-Qi | Director | 13.08% | NENG LV INTERNATIONAL CO., LTD. |
| Dong,Jiong-Xi | Director | 13.08% | NENG LV INTERNATIONAL CO., LTD. |
| Yang,Chao-Yu | Director | 0.36% | YUN CHEN INVESTMENT CO., LTD. |
| Yan,Wei-Qun | Independent Director | 0.00% | |
| Zheng,Long-Qing | Independent Director | 0.00% | |
| Wang,Jie-Chen | Independent Director | 0.00% |
Change Company Name to ABICO AVY CO., LTD.
2023/06/12
Change Company Name to NENGSU INNOVATION CO., LTD. (FORMER NAME: YINGHUA PRECISION TECHNOLOGY CO., LTD.)
2022/07/06
Change Company Name to ABICO AVY CO., LTD.
2021/08/11
Change Capital to 3,000,000,000
2020/06/18
Change Capital to 2,000,000,000
2019/04/16
Change Capital to 1,500,000,000
2018/08/29
Change Person in Charge to Dong,Jun-Ren
2013/06/26
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 2,086,383 | 9,433,375 | 9,420,948 |
| Operating cost | 1,775,038 | 7,921,697 | 7,892,316 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 311,345 | 1,511,678 | 1,528,632 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 311,345 | 1,511,678 | 1,528,632 |
| Operating expenses | 331,451 | 1,486,688 | 1,516,670 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -20,106 | 24,990 | 11,962 |
| Non-operating income and expenses | 245 | 248,591 | 219,258 |
| Net profit (loss) before tax | -19,861 | 273,581 | 231,220 |
| Income tax expense (benefits) | 31,973 | 165,399 | 113,439 |
| Net profit (loss) of ongoing business for the current period | -51,834 | 108,182 | 117,781 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -51,834 | 108,182 | 117,781 |
| Other comprehensive profit (loss), net | 157,778 | 379,499 | 90,146 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 105,944 | 487,681 | 207,927 |
| Net profit (loss) attributable to owners of parent company | -36,916 | 29,690 | 55,952 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -14,918 | 78,492 | 61,829 |
| Comprehensive profit (loss) attributable to owners of parent company | 23,919 | 313,472 | 214,532 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 82,025 | 174,209 | -6,605 |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -65,570 | 1,331,331 | 782,802 |
| Net cash inflows (outflows) from investing activities | -31,243 | -1,089,838 | -161,191 |
| Net cash inflow (outflow) from financing activities | -240,578 | 135,223 | -540,196 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 48,304 | 259,197 | -20,133 |
| Increase (decrease) in cash and cash equivalents in the current period | -289,087 | 635,913 | 61,282 |
| Beginning balance of cash and cash equivalents | 4,199,982 | 3,564,069 | 3,502,787 |
| Ending balance of cash and cash equivalents | 3,910,895 | 4,199,982 | 3,564,069 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 8,652,056 | 8,939,374 | 9,024,399 |
| Non-current asset | 6,764,100 | 6,838,213 | 6,314,365 |
| Total asset | 15,416,156 | 15,777,587 | 15,338,764 |
| Current liability | 5,826,107 | 5,986,142 | 5,289,066 |
| Non-current liability | 1,377,381 | 1,729,116 | 2,573,438 |
| Total liability | 7,203,488 | 7,715,258 | 7,862,504 |
| share capital | 1,689,590 | 1,689,590 | 1,689,590 |
| Equity - secruity token | - | - | - |
| capital reserve | 2,636,285 | 2,636,543 | 2,599,661 |
| retained earning | 1,545,744 | 1,619,001 | 1,665,288 |
| Other equity | -23,332 | -82,909 | -377,077 |
| Treasury stock | -5,714 | -5,714 | -5,714 |
| Total equity attributable to owners of parent company | 5,842,573 | 5,856,511 | 5,571,748 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 2,370,095 | 2,205,818 | 1,904,512 |
| Total Equity | 8,212,668 | 8,062,329 | 7,476,260 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 983,873 | 983,873 | 983,873 |
| Net asset value per share | 34 | 34 | 33 |
